title: Eye loss by exogenous endophthalmitis following anti-tumor necrosis factor therapy: a report of 3 cases.
authors.forename: Benoit
authors.initials: B
authors.lastname: Le Goff
authors.forename: Bertrand
authors.initials: B
authors.lastname: Vabres
authors.forename: Isabelle
authors.initials: I
authors.lastname: Cochereau
authors.forename: Beatrice
authors.initials: B
authors.lastname: Bouvard
authors.forename: Cedric
authors.initials: C
authors.lastname: Lamirel
authors.forename: Yves
authors.initials: Y
authors.lastname: Maugars
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Berthelot
mesh_terms: D000328:Adult; D000368:Aged; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D009877:Endophthalmitis / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014409:Tumor Necrosis Factor-alpha / Q000009:adverse effects*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha